Psychedelic Medicine

The death of a loved one following a cancer battle can trigger prolonged grief that can seemingly cause life to come to a standstill. It can also be hard to treat, leaving the griever 'stuck' in this stage. Now, magic mushrooms are offering fresh hope.

A new clinical trial has found that psilocybin combined with psychotherapy may be a promising treatment for anorexia nervosa, a mental illness that is notoriously difficult to treat and for which there are currently no approved medications.

In a world first, two illicit substances best known for their ‘recreational’ use have been given the tick of approval by Australian authorities to be prescribed for the treatment of post-traumatic stress disorder (PTSD) and drug-resistant depression.

Stunning nature, craft breweries, marionberries and Voodoo Doughnuts are some of the things the Pacific Northwest state is famous for, but with new licenses rolling out, it'll soon be known as the unofficial home of the burgeoning psilocybin industry.

Mandrake and henbane are almost synonymous with secret rituals. In fact, after analyzing hair samples from a secret cache in a Menorcan cave, new evidence indicates that plants like these were ingested during burial ceremonies about 3,000 years ago.

The results of a fascinating clinical trial challenge popular assumptions regarding "safer" strains of cannabis. The research found higher levels of cannabidiol (CBD) do not negate any potential adverse effects from smoking cannabis.

In a close result, voters in Colorado have passed the most progressive drug reform measure ever seen in the US, creating a regulatory framework for psychedelic clinics to operate and decriminalizing personal use of several natural hallucinogenic plants.

Most psychedelic advocates picture a future where the drug war is over and people are free to use a number of currently illicit substances but exactly how we get to that utopian future is the source of great acrimony in a previously unified community.

The world's first Phase 3 human trial for psilocybin-assisted therapy set to commence by the end of the year. The trial, run by Compass Pathways, will enroll close to 1,000 subjects and the company is looking to FDA approvals by the end of 2025.

New research has estimated legalization of cannabis over the past 25 years has cost pharma companies billions of dollars in lost sales. And, if cannabis were to be legalized across the entire US, pharma stocks could rapidly drop by over 10 percent.

For almost a century, popular culture has presented images of lazy, unmotivated "stoners" who do little more with their lives than smoke cannabis, but across a series of lab experiments and brain imaging tests a new study is busting that long-held myth.

A study has reported results from the first ever placebo-controlled trial testing psilocybin-assisted psychotherapy for alcohol use disorder, but the findings inadvertently raise major questions about the veracity of clinical trials for psychedelic drugs.